GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive.
Calico
8 followers
Mineralys Therapeutics
3 followers
Forge Biologics
2 followers
Immunome
2 followers
Pyxis Oncology
2 followers
Priovant
4 followers
BioTuring
1 follower
Qureator
1 follower
Centessa Pharmaceuticals
3 followers
Mariana Oncology
2 followers
MBX Biosciences
2 followers
Thermo Fisher Scientific
288 followers